- Home
- SGP vs CYRX Comparison
SGP vs CYRX Comparison
Compare SGP & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGP | CYRX |
|---|---|---|
| Founded | 2019 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.0M | 814.9M |
| IPO Year | 2026 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SGP | CYRX |
|---|---|---|
| Price | $29.11 | $16.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $45.00 | $13.31 |
| AVG Volume (30 Days) | 86.8K | ★ 440.9K |
| Earning Date | 05-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.06 | $7.61 |
| 52 Week High | $30.56 | $17.20 |
Technical Indicators
Market Signals| Indicator | SGP | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 61.56 |
| Support Level | $25.00 | $14.55 |
| Resistance Level | $29.90 | $16.87 |
| Average True Range (ATR) | 1.55 | 0.55 |
| MACD | -0.11 | 0.10 |
| Stochastic Oscillator | 55.78 | 86.56 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.